6. SGLT2 Inhibitors Have Some Favorable Effects on Nonalcoholic Fatty Liver Disease (NAFLD) Though the Alleviation of Hyperinsulinemia. This evidence concerns the gene SLC5A2 and metabolic dysfunction-associated steatotic liver disease.